Butyrate regulates the expression of inflammatory and chemotactic cytokines in human acute leukemic cells during apoptosis

Cytokine

Volumn 84, Issue , 2016, Pages 74-87

  Pulliam, Stephanie R ^a   Pellom, Samuel T ^a   Shanker, Anil ^a,b   Adunyah, Samuel E ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Acute myeloid leukemia; Butyrate; Cytokines; Inflammation; Migration

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BUTYRIC ACID; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; PROTEIN KINASE B; RANTES; VALPROIC ACID; APOPTOSIS REGULATORY PROTEIN; BUTYRIC ACID DERIVATIVE; CHEMOKINE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ACUTE LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL; CELL MIGRATION; CELL VIABILITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE EXPRESSION; HL 60 CELL LINE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; U937 CELL LINE; CELL LINE; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; HL-60 CELL LINE; LEUKEMIA; METABOLISM; MONONUCLEAR CELL; TUMOR CELL LINE; U-937 CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BUTYRATES; CASPASE 3; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CHEMOKINE CCL5; CHEMOKINES; GENE EXPRESSION; HL-60 CELLS; HUMANS; INFLAMMATION; LEUKEMIA; LEUKOCYTES, MONONUCLEAR; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; U937 CELLS; VALPROIC ACID;

EID: 84971653804     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2016.05.014     Document Type: Article

References (73)

1. Ozaki K., Leonard W.J. Cytokine and cytokine receptor pleiotropy and redundancy. J. Biol. Chem. 2002, 277:29355-29358.
2. Liongue C., O'Sullivan L.A., Trengove M.C., Ward A.C. Evolution of JAK-STAT pathway components: mechanisms and role in immune system development. PLoS ONE 2012, 7:e32777.
3. Paul W.E. Pleiotropy and redundancy: T cell-derived lymphokines in the immune response. Cell 1989, 57:521-524.
4. Chai E.Z., Siveen K.S., Shanmugam M.K., Arfuso F., Sethi G. Analysis of the intricate relationship between chronic inflammation and cancer. Biochem. J. 2015, 468:1-15.
5. Van der Jeught K., Bialkowski L., Daszkiewicz L., Broos K., Goyvaerts C., Renmans D., et al. Targeting the tumor microenvironment to enhance antitumor immune responses. Oncotarget 2015, 6:1359-1381.
6. Chow M.T., Luster A.D. Chemokines in cancer. Cancer Immunol. Res. 2014, 2:1125-1131.
7. Pulliam S.R., Uzhachenko R.V., Adunyah S.E., Shanker A. Common gamma chain cytokines in combinatorial immune strategies against cancer. Immunol. Lett. 2016, 169:61-72.
8. Cummings J.H. Short chain fatty acids in the human colon. Gut 1981, 22:763-779.
9. Roediger W.E. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980, 21:793-798.
10. Boffa L.C., Vidali G., Mann R.S., Allfrey V.G. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J. Biol. Chem. 1978, 253:3364-3366.
11. Davie J.R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 2003, 133:2485S-2493S.
12. Qiu J., Gao Z., Shima H. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis. Oncol. Rep. 2012, 27:160-167.
13. Mandal M., Kumar R. Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. Cell Growth Different.: Mol. Biol. J. Am. Assoc. Cancer Res. 1996, 7:311-318.
14. Pajak B., Orzechowski A., Gajkowska B. Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells. Adv. Med. Sci. 2007, 52:83-88.
15. Canani R.B., Costanzo M.D., Leone L., Pedata M., Meli R., Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 2011, 17:1519-1528.
16. Choi Y.H. Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity. Int. J. Oncol. 2006, 29:1207-1213.
17. Calabresse C., Venturini L., Ronco G., Villa P., Chomienne C., Belpomme D. Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line. Biochem. Biophys. Res. Commun. 1993, 195:31-38.
18. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., et al. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 1999, 18:1571-1583.
19. Rosato R.R., Almenara J.A., Cartee L., Betts V., Chellappan S.P., Grant S. The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells. Mol. Cancer Ther. 2002, 1:253-266.
20. Dai Y., Rahmani M., Grant S. An intact NF-kappaB pathway is required for histone deacetylase inhibitor-induced G1 arrest and maturation in U937 human myeloid leukemia cells. Cell Cycle 2003, 2:467-472.
21. Nakano K., Mizuno T., Sowa Y., Orita T., Yoshino T., Okuyama Y., et al. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 1997, 272:22199-22206.
22. Joseph J., Mudduluru G., Antony S., Vashistha S., Ajitkumar P., Somasundaram K. Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene 2004, 23:6304-6315.
23. Han S., Lu J., Zhang Y., Cheng C., Li L., Han L., et al. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region. Immunol. Lett. 2007, 108:143-150.
24. Nguyen K.A., Cao Y., Chen J.R., Townsend C.M., Ko T.C. Dietary fiber enhances a tumor suppressor signaling pathway in the gut. Ann. Surg. 2006, 243:619-625.
25. Sampson J.J., Donkor I.O., Huang T.L., Adunyah S.E. Novel piperazine induces apoptosis in U937 cells. Int. J. Biochem. Mol. Biol. 2011, 2:78-88.
26. Shanker A., Brooks A.D., Tristan C.A., Wine J.W., Elliott P.J., Yagita H., Takeda K., Smyth M.J., Murphy W.J., Sayers T.J. Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. J. Natl. Cancer Inst. 2008, 100:649-662.
27. Koumangoye R.B., Sakwe A.M., Goodwin J.S., Patel T., Ochieng J. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS ONE 2011, 6:e24234.
28. Bernhard D., Ausserlechner M.J., Tonko M., Loffler M., Hartmann B.L., Csordas A., et al. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 1999, 13:1991-2001.
29. Harris P., Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J. Leukoc. Biol. 1985, 37:407-422.
30. Birnie G.D. The HL60 cell line: a model system for studying human myeloid cell differentiation. British J. Cancer Suppl. 1988, 9:41-45.
31. Qin Z. The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 2012, 221:2-11.
32. Schildberger A., Rossmanith E., Eichhorn T., Strassl K., Weber V. Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide. Mediators Inflamm. 2013, 2013:697972.
33. Vaddi K., Newton R.C. Comparison of biological responses of human monocytes and THP-1 cells to chemokines of the intercrine-beta family. J. Leukoc. Biol. 1994, 55:756-762.
34. Altieri D.C., Edgington T.S. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J. Biol. Chem. 1988, 263:7007-7015.
35. Kawagoe R., Kawagoe H., Sano K. Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways. Leuk. Res. 2002, 26:495-502.
36. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001, 20:6969-6978.
37. Duenas-Gonzalez A., Candelaria M., Perez-Plascencia C., Perez-Cardenas E., de la Cruz-Hernandez E., Herrera L.A. Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat. Rev. 2008, 34:206-222.
38. van de Loosdrecht A.A., Ossenkoppele G.J., Beelen R.H., Broekhoven M.G., Langenhuijsen M.M. Cell cycle specific effects of tumor necrosis factor alpha in monocyte mediated leukemic cell death and the role of beta 2-integrins. Cancer Res. 1993, 53:4399-4407.
39. Peranzoni E., Zilio S., Marigo I., Dolcetti L., Zanovello P., Mandruzzato S., et al. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010, 22:238-244.
40. Borsig L., Wolf M.J., Roblek M., Lorentzen A., Heikenwalder M. Inflammatory chemokines and metastasis-tracing the accessory. Oncogene 2014, 33:3217-3224.
41. Wada T., Penninger J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004, 23:2838-2849.
42. Geest C.R., Coffer P.J. MAPK signaling pathways in the regulation of hematopoiesis. J. Leukoc. Biol. 2009, 86:237-250.
43. Huang P., Han J., Hui L. MAPK signaling in inflammation-associated cancer development. Protein Cell 2010, 1:218-226.
44. Fransecky L., Mochmann L.H., Baldus C.D. Outlook on PI3K/AKT/mTOR inhibition in acute leukemia. Mol. Cell. Therapies 2015, 3:2.
45. Ramakrishnan V., Pace B.S. Regulation of gamma-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway. Blood Cells Mol. Dis. 2011, 47:12-22.
46. Jung J.W., Cho S.D., Ahn N.S., Yang S.R., Park J.S., Jo E.H., et al. Augmentation of sodium butyrate-induced apoptosis by p38 MAP kinase inhibition in rat liver epithelial cells. Antioxid. Redox Signal. 2005, 7:1767-1772.
47. Cho S.D., Ahn N.S., Jung J.W., Yang S.R., Park J.S., Lee Y.S., et al. Critical role of the c-JunNH2-terminal kinase and p38 mitogen-activated protein kinase pathways on sodium butyrate-induced apoptosis in DU145 human prostate cancer cells. Eur. J. Cancer Prevent.: Off. J. Eur. Cancer Prevent. Org. 2006, 15:57-63.
48. Huang X.Z., Li Z.R., Zhu L.B., Huang H.Y., Hou L.L., Lin J. Inhibition of p38 mitogen-activated protein kinase attenuates butyrate-induced intestinal barrier impairment in a Caco-2 cell monolayer model. J. Pediatr. Gastroenterol. Nutr. 2014, 59:264-269.
49. Abe K. Butyric acid induces apoptosis in both human monocytes and lymphocytes equivalently. J. Oral Sci. 2012, 54:7-14.
50. Kalousek I., Brodska B., Otevrelova P., Roselova P. BimEL-dependent apoptosis induced in peripheral blood lymphocytes with n-butyric acid is moderated by variation in expression of c-myc and p21(WAF1). Cell Biochem. Funct. 2008, 26:509-521.
51. Conley B.A., Egorin M.J., Tait N., Rosen D.M., Sausville E.A., Dover G., et al. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin. Cancer Res. 1998, 4:629-634.
52. Mishra P., Banerjee D., Ben-Baruch A. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J. Leukoc. Biol. 2011, 89:31-39.
53. Moser B., Wolf M., Walz A., Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004, 25:75-84.
54. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
55. Lee H.W., Choi H.J., Ha S.J., Lee K.T., Kwon Y.G. Recruitment of monocytes/macrophages in different tumor microenvironments. Biochim. Biophys. Acta 2013, 1835:170-179.
56. Negus R.P., Stamp G.W., Relf M.G., Burke F., Malik S.T., Bernasconi S., et al. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Investig. 1995, 95:2391-2396.
57. Ueno T., Toi M., Saji H., Muta M., Bando H., Kuroi K., et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 2000, 6:3282-3289.
58. Arenberg D.A., Keane M.P., DiGiovine B., Kunkel S.L., Strom S.R., Burdick M.D., et al. Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol. Immunother.: CII 2000, 49:63-70.
59. Svensson S., Abrahamsson A., Vazquez Rodriguez G., Olsson A.K., Jensen L., Cao Y., et al. CCL2 and CCL5 are novel therapeutic targets for estrogen-dependent breast cancer. Clin. Cancer Res. 2015, 21(16):3794-3805.
60. Aldinucci D., Colombatti A. The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm. 2014, 2014:292376.
61. Xue G., Zippelius A., Wicki A., Mandala M., Tang F., Massi D., et al. Integrated Akt/PKB signaling in immunomodulation and its potential role in cancer immunotherapy. J. Natl. Cancer Inst. 2015, 107.
62. Bai Z., Zhang Z., Ye Y., Wang S. Sodium butyrate induces differentiation of gastric cancer cells to intestinal cells via the PTEN/phosphoinositide 3-kinase pathway. Cell Biol. Int. 2010, 34:1141-1145.
63. Wang Q., Zhou Y., Jackson L.N., Johnson S.M., Chow C.W., Evers B.M. Nuclear factor of activated T cells (NFAT) signaling regulates PTEN expression and intestinal cell differentiation. Mol. Biol. Cell 2011, 22:412-420.
64. Liu T.C., Lin P.M., Chang J.G., Lee J.P., Chen T.P., Lin S.F. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia. Am. J. Hematol. 2000, 63:170-175.
65. Kudo-Saito C., Shirako H., Takeuchi T., Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 2009, 15:195-206.
66. Rahmani M., Yu C., Reese E., Ahmed W., Hirsch K., Dent P., et al. Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition. Oncogene 2003, 22:6231-6242.
67. Diakos C., Prieschl E.E., Saemann M.D., Bohmig G.A., Csonga R., Sobanov Y., et al. N-Butyrate inhibits Jun NH(2)-terminal kinase activation and cytokine transcription in mast cells. Biochem. Biophys. Res. Commun. 2006, 349:863-868.
68. Rivero J.A., Adunyah S.E. Sodium butyrate induces tyrosine phosphorylation and activation of MAP kinase (ERK-1) in human K562 cells. Biochem. Biophys. Res. Commun. 1996, 224:796-801.
69. Witt O., Sand K., Pekrun A. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 2000, 95:2391-2396.
70. Jung J.W., Cho S.D., Ahn N.S., Yang S.R., Park J.S., Jo E.H., et al. Ras/MAP kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate. Cancer Lett. 2005, 225:199-206.
71. Scott D.W., Longpre J.M., Loo G. Upregulation of GADD153 by butyrate: involvement of MAPK. DNA Cell Biol. 2008, 27:607-614.
72. Kurita-Ochiai T., Amano S., Fukushima K., Ochiai K. Cellular events involved in butyric acid-induced T cell apoptosis. J. Immunol. 2003, 171:3576-3584.
73. Zhang Y., Zhou L., Bao Y.L., Wu Y., Yu C.L., Huang Y.X., et al. Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Chem. Biol. Interact. 2010, 185:174-181.